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Non-Water-Suppressed 1H MR 
Spectroscopy with Orientational 
Prior Knowledge Shows Potential 
for Separating Intra- and 
Extramyocellular Lipid Signals in 
Human Myocardium
Ariane Fillmer  1,2, Andreas Hock1,3, Donnie Cameron4,5 & Anke Henning1,6
Conditions such as type II diabetes are linked with elevated lipid levels in the heart, and significantly 
increased risk of heart failure; however, metabolic processes underlying the development of cardiac 
disease in type II diabetes are not fully understood. Here we present a non-invasive method for in vivo 
investigation of cardiac lipid metabolism: namely, IVS-McPRESS. This technique uses metabolite-
cycled, non-water suppressed 1H cardiac magnetic resonance spectroscopy with prospective and 
retrospective motion correction. High-quality IVS-McPRESS data acquired from healthy volunteers 
allowed us to investigate the frequency shift of extramyocellular lipid signals, which depends on the 
myocardial fibre orientation. Assuming consistent voxel positioning relative to myofibres, the myofibre 
angle with the magnetic field was derived from the voxel orientation. For separation and individual 
analysis of intra- and extramyocellular lipid signals, the angle myocardial fibres in the spectroscopy 
voxel take with the magnetic field should be within ±24.5°. Metabolite and lipid concentrations were 
analysed with respect to BMI. Significant correlations between BMI and unsaturated fatty acids in 
intramyocellular lipids, and methylene groups in extramyocellular lipids were found. The proposed IVS-
McPRESS technique enables non-invasive investigation of cardiac lipid metabolism and may thus be a 
useful tool to study healthy and pathological conditions.
Cardiac magnetic resonance spectroscopy (CMRS) is becoming increasingly popular as a non-invasive probe of 
myocardial metabolism1, permitting healthy and pathological conditions to be studied using different endoge-
nous nuclei. Of these, phosphorus (31P) is the most widely investigated, reflecting the crucial role of phosphorus 
metabolites in myocardial energetics. However, proton (1H) CMRS is starting to play a larger role in clinical 
research, as it permits visualisation of important molecular species including triglycerides and creatine (Cr). 
While the Cr resonance is an important clinical target, myocardial triglycerides are arguably of greater interest, 
as the healthy human heart obtains approximately 70% of its energy from oxidation of long-chain fatty acids1. 
Furthermore, elevated lipid concentrations in the heart are associated with type 2 diabetes mellitus2,3 and obesity4, 
as well as impaired diastolic function2,5 and a number of other disease conditions6,7. However, in order to gain 
deeper insights from lipid concentrations in cardiac muscle tissue concerning development of lipid metabolism 
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related cardiac disease, it is necessary to distinguish intramyocellular lipids (IMCL) from extramyocellular lipids 
(EMCL). Note that some publications have referred to these as intracardiomyocellular and extracardiomyocel-
lular lipids, ICCL and ECCL respectively8, but the terms IMCL and EMCL will be used throughout this work.
Applications of 1H MRS in human skeletal muscle have shown that up to four IMCL peaks and their corre-
sponding EMCL peaks can be discerned9–12 (see supporting information Fig. S1.1), while high resolution nuclear 
magnetic resonance studies on triglycerides13,14 found as many as nine independent peaks or multiplets in the 
triglyceride spectrum13,14. The two most prominent lipid moieties are attributed to intra- and extracellular meth-
ylene protons, while the others originate from, variously: methyl protons; methylene protons in esters; and meth-
ylene protons adjacent to unsaturated and polyunsaturated bonds in fatty acids, as well as protons attached to 
glycerol15,16. Although several of these peaks have been successfully resolved and separated into their EMCL 
and IMCL portions in skeletal muscle, in the myocardium they are harder to distinguish, and are thus typically 
considered as a whole4,8,17–22. Accurate separation of the two sets of lipid moieties would be of great interest: first, 
to explore IMCL’s utility as a pathological marker and its role as an energy substrate23; and second, to investi-
gate whether EMCL is metabolically significant, and not just an inert adipocyte depot24. To date, only the most 
prominent lipid resonances have been used for quantification, with some works considering only the highest 
resonance25, and others assuming constant area ratios between different lipid resonances8. Robust separation 
of lipid signals from the two different compartments in human subjects, as well as a comprehensive analysis of 
these myocardial lipids, has not been forthcoming. This can be attributed to relatively poor spectral quality in 
1H CMRS, caused by a number of factors, including static field inhomogeneities, poor water suppression, inad-
equate localisation, and cardiac and respiratory motion26. Furthermore, the chemical shift of the EMCL peaks 
exhibits a dependence on muscle fibre orientation with respect to the main magnetic field9,10, sometimes leading 
to substantial overlap with the IMCL peaks, which have a fixed chemical shift. To achieve separate and accurate 
quantification of IMCL and EMCL, these challenges must first be surmounted.
Several methods have been applied to improve spectral quality in 1H CMRS, including: rapid 
single-breath-hold acquisitions25; prospective volume-tracking27,28; respiratory gating with pressure transduc-
ers, radar techniques, or navigator echoes27,29–31; and improved image-based B0 shimming to compensate for 
static field inhomogeneities across the heart32,33. All of these methods were applied with routine electrocardio-
gram (ECG) triggering. Just as important as acquisition strategies, post-processing methods can also improve 
the quality of 1H CMRS spectra, with frequency alignment and phase correction of individual signal averages 
serving to minimise line-broadening and phase-cancellation that result from cardiac motion and transient B0 
inhomogeneities34. While frequency alignment and phase correction can improve spectral quality, they require a 
strong reference peak to be effective and, given 1H CMRS is commonly applied with water suppression, a strong 
peak may not be available. Moreover, water suppression could interfere with navigator signals, leading to poor 
respiratory gating. These issues can be avoided, and the robustness of 1H CMRS can be improved, through the use 
of a metabolite-cycled (MC) non-water-suppressed spectroscopy34–36 sequence: a two-shot subtraction technique 
where the water peak is retained as a reference for spectral correction.
This work introduces the inner-volume-saturated, metabolite-cycled point resolved spectroscopy 
(IVS-McPRESS) method for robust, high quality 1H CMRS in the human heart. This method is a combination 
of MC non-water-suppressed 1H CMRS with point resolved spectroscopy (PRESS)37 localisation and inner vol-
ume saturation (IVS)38,39 together with cardiac triggering, retrospective respiratory gating, sophisticated B0 shim-
ming33, and post-processing methods34. Furthermore, conditions for the reliable resolution of the different lipid 
moiety signals are investigated, for use in both cardiac and skeletal muscle studies. Combination of this analysis 
with the IVS-McPRESS acquisition method will enable the separate investigation of IMCL and EMCL compo-
nents, allowing for detailed examination of myocardial lipid metabolism.
Methods
Theory. Metabolite quantification of both 1H MR skeletal muscle spectra and 1H MR cardiac muscle spectra 
is complicated by effects induced by the fibre structure of the tissue. Regarding lipid quantification, so-called bulk 
susceptibility effects are of particular interest.
Bulk Susceptibility Effects. IMCL and EMCL have identical chemical compositions, but experience differ-
ent chemical shifts (see supporting information Fig. S1.1); studies in skeletal muscle have shown this to be a result 
of bulk susceptibility effects9,11. While the resonance frequencies of IMCL signals are fixed, the chemical shift of 
EMCL depends on the angle, θ, muscle fibres take relative to the main magnetic field (B0)9,10. Four of these angles 
are expected to give identical shifts: θ, θ− , pi θ− , and pi θ− +  (Fig. 1a). Working under the assumption that EMCL 
is confined between filamentary muscle cells to a tubular form, Boesch et al.9 calculated that the difference of the 
EMCL chemical shift with respect to the IMCL resonance frequency, ω∆ EMCL, ranges from −0.1 ppm to 
+0.21 ppm, with these extremes occurring when the tubular structures, and hence the muscle fibres, are aligned 
perpendicular or parallel to B0, respectively. Therefore, EMCLω∆  can be expressed in terms of θ as follows:
ω θ θ∆ = . ⋅ − .( ) 0 31 cos ( ) 0 1, (1)EMCL
2
an even, periodic function with four zero-crossings within the range pi−  to pi and with maxima (0.21 ppm shift) 
and minima (−0.1 ppm shift) occurring at n /2θ pi= ⋅ , where n is a natural number. The total range of frequen-
cies, ω θ∆ ( )EMCL  can assume, spans therefore 0.31 ppm.
Assuming consistent voxel positioning relative to cardiac fibre orientation, EMCLω∆  can also be expressed in 
terms of α, the angle the voxel takes with B0 (Fig. 1b). Therefore, ( )EMCLω α∆  may be described by:
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ω α ρ α α∆ = ⋅ . ⋅ − − .θ( ) cos ( ) 0 31 cos ( ) 0 1, (2)EMCL
2 2
where ρ denotes the fibre orientation relative to the rotation plane, assuming the whole system of voxel and myo-
cardial fibres could be rotated around an axis perpendicular to B0, and αθ is the fibre angle relative to the plane the 
voxel orientation spans with the rotation axis. While the heart is certainly not being rotated in the scanner, this 
theoretical concept describes all possible relative orientations between the voxel, the myocardial fibres, and B0. 
More details of this substitution are given in chapter 2 of the supporting information.
MRS Pulse Sequence. A PRESS37 localisation was employed in combination with the MC technique35. The 
MC method applies an upfield or downfield inversion pulse before alternate PRESS shots, inverting the metab-
olites upfield or downfield of the water peak, respectively, but leaving the water peak untouched. By subtract-
ing the downfield-inverted spectra from the upfield-inverted spectra, a spectrum without water signal can be 
calculated, obviating the need for lengthy water-suppression techniques. By adding the downfield-inverted and 
upfield-inverted spectra, this technique allows the calculation of a pure water spectrum, from which water peak 
linewidths can be obtained without the need for an additional scan. In order to improve localisation and mini-
mise the chemical shift displacement artefact, six inner-volume saturation (IVS)38,39 bands were also applied. This 
acquisition method will henceforth be referred to as IVS-McPRESS; a sequence diagram is displayed in Fig. 2.
Data acquisition. Measurements were performed using a 3 T Achieva MR system with a 32-channel cardiac 
receive array coil (Philips Healthcare, Best, NL) in 10 healthy female volunteers: median (range) age = 26 (21–30) 
years; median (range) body mass index (BMI) = 21.2 (17–27.3) kg/m2; median (range) heartrate = 58.5 (≈50 to 
≈80) bpm. All volunteers gave written informed consent according to the guidelines of the cantonal ethics board 
of Zurich. All methods were performed in accordance with the relevant guidelines and regulations. 
Navigator-gated balanced steady-state free-precession cine images of short axis and quasi-four-chamber views of 
the heart were used to plan the spectroscopy voxel (Fig. 3) in the interventricular septum. ECG-triggered and 
respiratory-gated B0 maps were acquired to serve as a basis for B0 shim calculations using an image-based 
Shimtool32,33. Linear shim settings were optimised over the voxel of interest, and an automatically weighted region 
of less interest (ROLI) covering the whole heart was also considered during the calculation33. The IVS-McPRESS 
Figure 1. Voxel positioning with respect to fibre orientation and main magnetic field B0. The chemical shift of 
extramyocellular lipid (EMCL) resonances depends on the angle θ between the muscle fibres and the magnetic 
field (B0). (a) Since only the angle with the B0 axis is relevant, four angles θ, θ− , pi θ− , and pi θ− +  in the range 
pi−  to pi can be considered equivalent and will result in the same ω∆ EMCL. (b) Assuming consistent voxel 
placement with respect to the muscle fibre orientation, the dependence can be examined with respect to the 
angle α between the voxel itself and B0. However, any offset between the two angles α and θ also needs to be 
accounted for, as does the possibility that the voxel and the muscular fibres are oriented differently with respect 
to the axis orthogonal to B0, which might result in θ not assuming the full range of values between pi−  and pi, 
while α is swept through the whole range from pi−  to pi. A more detailed explanation of this can be found in the 
supporting information. Note that this figure is intended as an illustration of how the different angles are 
related., and is not meant to imply that the myocardial fibres are oriented parallel to the shortest axis of the 
measurement voxel.
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sequence was applied with an effective voxel size of 9.2 × 6.1 × 18.7 mm3, a minimum repetition time ≥3 heart 
beats, an echo time of 32 ms, and an acquisition time of 512 ms. Furthermore, it was ECG-triggered to end systole 
(trigger delay approx. 250 ms) and respiratory motion was measured using a navigator placed at the right 
hemi-diaphragm. Due to a lack of volume-based, ECG-triggered routines for flip angle optimisation, optimum 
flip angles were approximated manually by iterating through different transmit voltages for single shot non-water 
suppressed spectral acquisitions of the target voxel until the water peak intensity was maximised. The angle α 
between the voxel and B0 was read out from the parameter file (header file) of the acquired data.
A total of 256 averages were recorded within each IVS-McPRESS measurement, which took approximately 
13 minutes, depending on the volunteer’s heartrate. The measurement was then repeated until the end of the 
allocated 2-hour timeslot. This led to a minimum of 512 averages acquired per subject, except for one case, where 
only 448 averages were acquired; however, the latter data set showed an excellent signal-to-noise ratio (SNR) of 
25, as compared to the mean (standard deviation, SD) SNR of 21.4 (10.6), and was thus retained for analysis.
Post-processing. MRecon (Gyrotools, Zurich, CH) was used to access raw data and to perform singular 
value decomposition coil combination. The individual signal acquisitions were zero-filled to twice their original 
size prior to phase- and eddy-current-correction, and frequency-aligned (see supporting information Fig. S3.1) 
to the unsuppressed water peak. Afterwards, each acquisition was truncated to 100 ms, at which point the signal 
Figure 2. A sequence diagram of the proposed IVS-McPRESS technique. After the recording of a navigator 
signal to assess the breathing status of the volunteers, an inner volume suppression (IVS) scheme is applied to 
improve the robustness of the localisation. Then an upfield or downfield inversion pulse is applied in alternating 
measurements, inverting all upfield or all downfield metabolites, respectively, while leaving the water signal 
untouched. Finally, a point resolved spectroscopy (PRESS) localisation is employed. The sequence is initiated by 
an ECG trigger, with the excitation pulse occurring approximately 250 ms after that, with the total duration of 
all radio frequency pulses being 120 ms. By subtraction of an upfield and a downfield inverted measurement, a 
metabolite spectrum without water signal can be generated.
Figure 3. Voxel positioning. An end systolic short-axis view (a) and a quasi-4-chamber view (b) of a volunteer’s 
heart are shown. The spectroscopy voxel was placed in the interventricular septum, with the effective 
acquisition volume indicated in orange. The red and white boxes indicate the excitation volume at 4.6 ppm 
(water frequency) and at 2.0 ppm, respectively, which differ due to chemical shift displacement. Inner-volume 
saturation (IVS) bands (blue) are used to saturate areas of the voxel that are subject to only partial excitation in 
the desired frequency range, due to chemical shift displacement, thus increasing localisation robustness.
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has completely decayed, to avoid noise amplification due to overlong acquisition times. Each truncated acqui-
sition was then zero-filled a second time to double the lengths of the original signal acquisition. Afterwards, 
the upfield-inverted spectra and the downfield-inverted spectra were averaged individually and subtracted from 
one another to produce a full IVS-McPRESS spectrum. A second spectrum was then calculated where all FIDs 
acquired with a navigator offset of more than 8 mm from the expiration position were discarded prior to averag-
ing. If the latter data showed lower SNR than the spectrum calculated from all acquired averages, it was assumed 
that the volunteer primarily performed abdominal breathing and heart displacement due to respiratory motion 
was negligible. Hence, of the two calculated spectra, only the one with the largest SNR was retained for further 
analysis, where SNR is defined as the maximum signal within the analysis window of the spectrum, minus the 
baseline, divided by twice the root mean square of the residual, as reported by LCModel40.
Quantification. In order to fit and quantify the spectral components of the acquired spectra the standard 
tool LCModel40 was used with the ‘muscle-5’ setting, assuming that - as a first approximation - cardiac muscle 
tissue has a similar composition to skeletal muscle tissue. LCModel, with the ‘muscle-5’ setting, is widely-used for 
quantification of 1H skeletal muscle spectra; it does not require the input of a basis set, and is thus less prone to 
user-dependent results than other tools.
IMCL resonances (IMCL09, CH3 at 0.9 ppm; IMCL13, CH2 at 1.3 ppm; and IMCL21, CH2 close to double 
bindings in lipid chain at 2.1 ppm) and EMCL resonances (EMCL11, CH3 at 1.1 ppm; and EMCL15, CH2 at 1.5 
ppm) were analysed, along with the sum of CH2 next to the glycerin from IMCL and CH2 close to double bindings 
in lipid chain from EMCL at 2.3 ppm (I/E23), trimethyl-ammonium (TMA) compounds at 3.2 ppm, and taurine 
(tau) at 3.4 ppm. Relative concentrations were calculated for all metabolites using the creatine resonance (Cr30) 
at 3.0 ppm as a reference. Since the Cramér–Rao lower bounds (CRLBs) of the creatine signal at 3.9 ppm (Cr39), 
as calculated by LCModel, were very high compared to the CRLBs of other metabolites (see Table 1), the Cr39 
resonance was excluded from further quantification analysis.
Finally, the metabolite/Cr ratios were analysed with respect to the BMI of the volunteers. Pearson’s correlation 
coefficient was determined in MATLAB (The Mathworks, Natick, MA, USA) for all identified metabolites in 
order to identify any statistically significant correlations.
IMCL and EMCL Signal Separation. The frequency shift, EMCLω∆ , of the largest EMCL signal, EMCL15, 
with respect to the corresponding IMCL signal, IMCL13, was extracted from the LCModel fit results. To investi-
gate the dependence of EMCLω∆  on α, the angle between the voxel and the main magnetic field, the parameters of 
equation (2) were fitted to the data. To verify this model is appropriate to describe the observed angulation 
dependence of the chemical shift of EMCL, adjusted R2values and corrected Akaike information criterion (AICc) 
values were obtained for this model and a linear regression model that served as null hypothesis.
Prior Knowledge for Quantification. To investigate the utility of the angular dependence of EMCL chem-
ical shifts as prior knowledge for quantification, the spectra were fitted again using an undocumented parameter 
in LCModel, ‘chsimu’, which allowed the chemical shifts of the four major lipid components, IMCL13, EMCL15, 
IMCL09, and EMCL11, to be fixed, independent of their usual bounding conditions. During this procedure, the 
chemical shift of the most prominent resonance, IMCL13ω , was fixed to the value determined during the first fitting 
session, as this was deemed to be the most reliable frequency value. The chemical shift of the IMCL09, IMCL09ω , 
resonance was then calculated by:
ω ω= − .0 4 ppm, (3)IMCL IMCL09 13
volunteer
demographics IMCL13 EMCL15 IMCL09 EMCL11 IMCL21 I/E23 TMA tau Cr39
age 
[y]
BMI 
[kg/m2]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
Cr 
ratio
CRLB 
[%]
1 23 20.18 1.45 5 1.39 5 — — 0.25 20 0.33 12 1.33 7 0.49 7 0.47 10 0.34 12
2 21 27.34 2.47 3 1.24 5 0.22 16 0.25 15 1.42 7 1.50 7 0.65 6 0.38 17 0.05 52
3 25 19.14 3.82 1 0.06 36 0.80 7 0.06 28 0.62 17 2.19 8 0.95 3 0.53 10 — —
4 26 22.58 3.30 2 0.49 15 0.63 4 0.07 30 0.83 9 1.94 6 0.75 3 0.47 8 0.04 20
5 27 23.80 4.17 3 0.72 13 0.66 8 0.52 16 1.15 15 2.51 9 0.92 3 0.41 12 0.02 76
6 28 17.01 2.13 1 0.17 17 0.33 6 0.13 13 0.42 8 2.56 3 0.83 3 0.22 12 0.11 15
7 27 22.21 2.94 3 0.19 37 0.70 8 0.25 22 1.11 9 2.89 5 0.52 7 0.40 12 0.50 12
8 25 17.26 1.18 2 0.06 26 0.33 5 0.01 83 0.44 7 1.90 3 0.76 3 0.27 9 0.12 11
9 26 19.03 1.93 2 0.26 8 0.38 6 0.14 13 0.96 4 1.43 4 0.69 3 0.24 12 0.02 43
10 30 22.48 2.35 2 0.22 17 0.83 5 0.02 75 1.47 5 2.11 4 0.69 3 0.18 15 0.00 604
Mean 
(SD)
26.33 
(2.00)
21.10 
(3.20)
2.57 
(0.98)
2.40 
(1.17)
0.48 
(0.48)
24.10 
(22.54)
0.54 
(0.23)
7.22 
(3.56)
0.17 
(0.15)
31.50 
(25.77)
0.88 
(0.41)
9.30 
(4.19)
2.04 
(0.52)
5.60 
(2.12)
0.72 
(0.15)
4.10 
(1.79)
0.36 
(0.12)
11.70 
(2.71)
0.13 
(0.17)
93.89 
(192.63)
Table 1. Metabolite/Cr ratios and Cramér-Rao-Lower-Bounds (CRLB) from LCModel given for each volunteer. 
The italic cells indicate the volunteers with the highest and lowest angle α, respectively, which were excluded 
from analysis with regard to lipid quantification. Means and standard deviations (SD) over all volunteers are 
given in the bottom row.
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and the chemical shift of the EMCL15 and EMCL11 resonances, EMCL15ω  and EMCL11ω , were calculated by:
ω ω ω= + ∆ , (4)EMCL IMLCL EMCL15 13
, (5)EMCL IMCL EMCL11 09ω ω ω= + ∆
using ω∆ EMCL as determined from equation (2) with the obtained fit parameters for ρ and αθ, and values for α 
read from the parameter file.
The newly obtained metabolite/Cr ratios were again investigated with respect to BMI, and Pearson’s correla-
tion coefficients were determined to identify statistically significant correlations.
Results
The mean (SD) of the water peak linewidths over all volunteers was 18 (1) Hz before correction and was fur-
ther reduced to 12 (1) Hz with frequency alignment (see supporting information Fig. 3.1), and phase- and 
eddy-current-correction. A representative spectrum is displayed in Fig. 4, together with the LCModel fit and the 
fitted basis functions. The mean (SD) SNR of all measurements was 21 (11). Table 1 displays metabolite/Cr ratios 
and CRLBs as calculated by LCModel.
IMCL and EMCL Signal Separation. In Fig. 5, ω∆ EMCL is plotted versus α, together with a fit of equation 
(2), which shows the dependence of the theoretical frequency shift of EMCL on α. Clearly, the EMCLω∆  of the 
spectra closely follows the angular dependence given by equation (2), with a coefficient of determination, R2, of 
0.89. The calculated fit parameters were α = .θ 0 15rad (α = . °θ 8 6 ) and 0 13radρ = .  (ρ = . °7 2 ). The two data 
points associated with the largest and the smallest α, however, are clear outliers, represented by open circles. 
Given that the frequency shift of EMCL15 is expected to depend on α, as per equation (2), and the other data 
points in Fig. 5 follow this relationship, the frequency shifts of the outlier data are expected to be significantly 
smaller than the values shown. In fact, in these outlier data we expect the EMCL15 resonances to show the small-
est ω∆ EMCL among all acquired spectra. By visual inspection of the spectra in question, a small ‘shoulder’ was 
apparent on the IMCL13 peak at the predicted frequency for EMCL15 (see supporting information Fig. 4.1). The 
reason this shoulder may not have been fitted is that the fit parameter that determines the frequency shift of the 
basis functions within LCModel is internally constrained, with the constraint values depending on several prop-
erties of the acquired spectrum, like SNR and linewidth. Furthermore, triglyceride spectra exhibit an additional 
low intensity spectral component at 1.6 ppm13,14,16, stemming from the methylene protons next-nearest to the 
glycerol in IMCL, which is not included in the fitting model used by LCModel. Indeed, the two outlier spectra 
showed fitted EMCL15 peak areas of the same order of magnitude as the noise, and it is therefore likely that the 
EMCL15 basis function was fitted either to noise or to the very low intensity signal of IMCL at 1.6 ppm in these 
cases. Hence, these two spectra were excluded from further analysis.
The remaining eight spectra, in which EMCLω∆  was close to theoretically derived values, were acquired with a 
voxel angle α within the range of α− . < < .0 26rad 0 56rad ( 15 32α− ° < < °), which translates to roughly 
24 5 24 5θ− . ° < < . ° using equation (S.20) from the supporting information.
Excluding the outliers, which result from constraints on the LCModel fit, the adjusted R2 and AICc values for 
the model described by equation (2) were calculated as 0.86 and −93, respectively; whereas a linear model gave 
adjusted R2 and AICc values of 0.03 and −71. Hence, the likelihood of equation (2) being the correct model cal-
culated to 99.96%, which is 2436.6 times the likelihood of the linear model.
Quantification. In Fig. 6 the Cr ratios of IMCL13 (a), IMCL21 (b), EMCL11 (c), EMCL15 (d), and tau (e), as 
given by LCModel, are plotted versus the BMI of the volunteers. It can be seen in Fig. 6(b) that the IMCL21 ampli-
tude correlates significantly with the volunteers’ BMIs ( < .p 0 05). The signal at 2.1 ppm stems from methylene 
protons adjacent to unsaturated bonds in fatty acids in IMCL. Hence, it appears that a larger BMI leads to a 
greater concentration of IMCL unsaturated fatty acids in the myocardium. Furthermore, the other lipid moieties 
shown in the Fig. (a,c,d), and taurine (e), also exhibit a strong positive correlation with BMI that is not statistically 
significant, likely due to the small sample size. Since the EMCL11 signal stems from the end groups of the lipid 
chains, this suggests a greater number of lipid molecules in extramyocellular fat, and more saturated bonds in 
fatty acids in both compartments (IMCL13 and EMCL15), with larger BMIs. Moreover, greater BMI seems to be 
linked to an increase in the less abundant metabolite taurine. Quantification results of other metabolites without 
strong correlations to BMI can be seen in the supporting information (Fig. S5.1).
Prior Knowledge for Quantification. Figure 7a shows the spectra of all 10 volunteers in the frequency 
range from 0.6 ppm to 1.8 ppm, which includes the four most prominent lipid moieties: IMCL13, EMCL15, 
IMCL09, and EMCL11. Also shown is the LCModel fit using prior knowledge about chemical shifts of EMCL, 
calculated according to equations (3), (4) and (5). Spectra and fits were scaled to the Cr peak. The EMCL compo-
nents are clearly distinguishable by eye in some cases, but merge with the IMCL peaks in others. Table 2 displays 
the quantification results of these prior knowledge fits. Comparing the CRLBs of the prior knowledge fits of the 
lipid moieties here to those of the fits without prior knowledge, the overall CRLBs of IMCL moieties appear to 
increase only marginally, but decrease substantially for the EMCL components. This indicates that employing 
prior knowledge of the chemical shift of EMCL components, obtained through calculations from the voxel angle, 
increases the robustness of quantification results.
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Figure 4. Measured 1H MR spectrum from the myocardium of a volunteer. The measured spectrum is 
shown (black, top panel) along with the fit (red, top panel). Different lipid components are indicated in green 
(intramyocellular lipids, IMCL) and blue (extramyocellular lipids, EMCL). The resonance from the IMCL 
resonance at 2.3 ppm and from the EMCL resonance corresponding to IMCL21, but shifted due to susceptibility 
effects to 2.3 ppm are approximated with only one basis set by LCModel. The mixed signal I/E23 of these two 
moieties is marked in purple. The middle panel displays the residuum of the LCModel fit. The different fitted 
basis functions from LCModel are shown in the bottom panel with the assigned metabolites on the right. 
Several metabolites are fitted as the sum of different slightly shifted peaks by LCModel to take effects on line 
shape, such as dipolar coupling, into account. In this case 1024 averages were acquired. Since respiratory motion 
effects did not have a negative effect on the spectrum’s SNR and line shape, no averages were discarded.
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In Fig. 7b–e the quantification results for the four lipid components are plotted versus BMI. The EMCL15/Cr 
ratios obtained from the prior knowledge fits correlate significantly ( < .p 0 05) with the volunteers’ BMIs 
(Fig. 7d). Note that in this case all data points are included in the analysis.
Discussion
We have demonstrated that the newly-introduced IVS-McPRESS technique is capable of very high spectral data 
quality, which likely enables the separation and isolated analysis of IMCL and EMCL components in the myocar-
dium for the first time, as well as the analysis of less abundant metabolites, such as trimethylamine (TMA) and 
taurine (tau). This is possible because very narrow linewidths were achieved. Unfortunately, many publications 
fail to report the average water peak linewidths of their spectra, making a proper comparison difficult. Positive 
exceptions are Bottomley et al.41, Machann et al.42 and Rial et al.25, who reported mean (SD) linewidths of 19 (8) 
Hz, 13 to 17 Hz, and 13.3 (2.4) Hz at 3 T, respectively. Although the linewidth reported in the last of these publi-
cations is comparable to the mean (SD) water peak linewidth of 12 (1) Hz shown in our study, it should be noted 
that Rial et al.25 extracted the linewidth from spectra of only four signal averages acquired in a single breath-hold, 
thus avoiding the most important line-broadening issues like respiratory motion and thereby introduced field 
fluctuations. Such an approach, however, compromises the spectral SNR, making reliable metabolite quantifi-
cation challenging, particularly for less abundant metabolites. Weiss et al.43 and Van der Meer et al.5 reported 
average water peak linewidths of 8.6 Hz (1.5 Hz) and 10.7 Hz (0.4 Hz) at 1.5 T, respectively; however, at this field 
strength, linewidths are expected to be approximately half the widths of those observed at 3 T. The narrow line-
width at 3 T in this study was achieved via: (1) a small voxel size; (2) the use of IVS for robust localisation to the 
interventricular septum; (3) a sophisticated image-based B0 shimming strategy; and (4) a non-water suppressed 
MRS sequence in conjunction with ECG triggering and navigator respiratory-motion tracking, which allowed 
for prospective and retrospective motion correction, as well as frequency alignment and phase correction during 
post-processing. Moreover, the measurements shown here were acquired on a 3 T system, while most 1H CMRS 
studies so far were performed at 1.5T1. The increased field strength results in a higher SNR and thus counteracts 
SNR loss resulting from the small voxel size. Furthermore, it leads to an increased frequency shift of the EMCL 
resonances with respect to the IMCL frequencies, facilitating more reliable separation of both signals.
Our investigation of the chemical shift difference between EMCL15 and IMCL13, ω∆ EMCL, and its depend-
ence on the angle the voxel takes with the static magnetic field B0, proves the feasibility of reliably separating sig-
nals from IMCL and EMCL within the human myocardium with the proposed technique. However, we also 
demonstrate that robust separation of signals from the different lipid compartments is only reliably possible if the 
mean angle, θ, of the myocardial muscle fibres with B0 in the voxel of interest is between θ− . ° < < . °24 5 24 5 , the 
range where EMCLω∆  is large enough for the two signals from the different compartments to be resolved. 
Furthermore, we demonstrated that employing prior knowledge about the chemical shift of the EMCL signals 
improves robustness and reliability of quantification results. This prior knowledge can be derived from the voxel 
orientation with respect to B0, if certain conditions are met, like consistent voxel positioning with respect to 
myofibre orientation. However, at angles α where the resonances of the two lipid moieties coincide at the same 
frequency, separation of signals from the two lipid compartments is impossible. Hence, care must be taken during 
the positioning and angulation of the examination voxel along the curved surface of the interventricular septum. 
It is worth pointing out that there is a smooth transition of myocardial fibre orientations from endocardium to 
epicardium through the septum44–46; however, the peak position of the EMCL signal will correspond to the mean 
fibre orientation, with the linewidth depending on the distribution of fibre orientations within the voxel (see the 
Figure 5. The angular dependence of lipid peak separation. Chemical shift difference of EMCL15 with respect 
to IMCL13, EMCLω∆  plotted over α, the angle between the voxel and B0. A fit of equation (2) is indicated by the 
red curve. Calculated fit parameters are 0 15 radα = .θ  and ρ = .0 125 rad, and the corresponding coefficient of 
determination, R2, is 0.89. Two outliers (open circles), acquired with the largest and smallest angle α, 
respectively, were excluded from the fit and from all following analysis, since the chemical shift range of the 
LCModel fit is constrained and is likely unable to correctly fit the frequency position of the peaks in question. 
The smaller plot on the right displays the course of the fit of equation (2) in the range from −pi to pi.
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supporting information for further details). Nevertheless, data from this study are in excellent accordance with 
both the findings for skeletal muscle regarding the dependence of the chemical shift of EMCL signals on fibre 
orientation reported by Boesch et al.9 and the theoretical considerations laid out in the appendix of the same 
reference. Our findings add to this body of literature, and will permit improved lipid quantification in skeletal 
muscle as well as myocardium. However, the findings of this study are based solely on examinations in healthy 
volunteers, and need to be evaluated in pathological conditions where myocardial fibre structure is altered, such 
as myocardial infarction47, which leads to structural remodelling.
In this study Cr39 was excluded from more detailed analysis, as its CRLBs calculated by LCModel were high, 
and quantification was thus unreliable. The poor quality of this resonance could result from signal loss caused by 
Figure 6. Correlations of metabolite/Cr ratios with BMI. IMCL13/Cr (a), IMCL21/Cr (b), EMCL11/Cr (c), 
EMCL15/Cr (d), and tau/Cr (e) plotted versus the body mass index (BMI) of the healthy volunteers. Data 
points that were excluded from analysis are shown as open circles. Linear regressions are displayed as red lines, 
and Pearson regression coefficients, r, and significance values, p, are given for each data set. It can be seen (b) 
that the IMCL21/Cr ratio correlates significantly with BMI. Although not statistically significant, the other 
metabolite/Cr ratios shown here do exhibit a strong positive correlation with BMI, suggesting that not only 
unsaturated bonds in IMCL fatty acids (IMCL21) are increased at high BMIs, but also the number of lipid 
molecules in EMCL, the number of saturated bonds in fatty acids of both compartments, as well as taurine. 
Other metabolite/Cr ratios that do not show a strong correlation with BMI can be found in the supporting 
information (Fig. S5.1).
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Figure 7. New quantification from LCModel fits incorporating prior knowledge about the chemical shift of 
lipid resonances. (a) Spectra from all ten volunteers in the range from 0.6 ppm to 1.8 ppm are shown (upper 
panel) together with the fit curves (lower panel) derived from LCModel using the undocumented’chsimu’ 
parameter to fix the chemical shifts of the most prominent lipid components with respect to each other to the 
frequencies calculated by equations (3) to (5). Spectra and fits were scaled to match the intensity of the Cr peaks 
(not shown). While in some cases the EMCL resonances are clearly visible and separated from the IMCL 
resonances, in other cases the EMCL resonance merges into the IMCL peaks and separation becomes more 
difficult. Quantification results for IMCL13/Cr (b), IMCL09/Cr (c), EMCL15/Cr (d), and EMCL11/Cr (e) from 
these fits were plotted against the volunteers’ BMIs. Linear regressions are displayed as red lines, and Pearson’s 
correlation coefficients, r, and significance values, p, are given for each. It can be seen that the EMCL15/Cr ratio 
exhibits a significant correlation (p 0 04= . ) with the volunteers’ BMIs. Note that, in this case, all data points are 
included in the analysis, since the inability of the standard LCModel algorithm to reliably quantify EMCL 
moieties if EMCLω∆  is too small, was corrected in this case by using the ‘chsimu’ parameter, which allowed fixing 
of the chemical shifts of the lipid components to frequency values calculated with equations (3), (4), and (5).
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imperfect inversion by the MC pulse, due to its proximity to the water resonance. Furthermore, the frequency 
fluctuations between individual signal acquisitions (shown in Fig. S3.1 in the supporting information) by cardiac 
and respiratory motion caused partial inversion of the water resonance, to varying extents in different acquisi-
tions. This, and the heartrate dependent TR, led to spectra with fully-relaxed metabolite signals, but only partly 
– and inconsistently over different volunteers – relaxed water signals made water an unreliable quantification 
reference in this study (T1 values of methylene groups and water in skeletal muscle are <0.5 s and approximately 
1.4 s, respectively48). Hence, for water referencing a non-water-suppressed acquisition with sufficient TR and with-
out metabolite cycling will be required in future CMRS work, although metabolite cycling theoretically offers the 
option to calculate a pure water signal without an additional scan. Clearly, further improvement of quantification 
will require a more rigorous investigation of relaxation rates of different spectral components in cardiac muscle.
Due to the lack of standardised analysis tools for 1H CMRS, the analysis and quantification of 1H spectra 
acquired from the myocardium remains challenging. In a first approach to analyse the spectral data acquired from 
the hearts of volunteers, it was assumed that the heart is a muscle and its chemical composition would be similar 
to that of skeletal muscle. Hence, the spectral basis sets of a skeletal muscle model in the standard spectroscopy 
analysis tool LCModel were presumed to suffice for approximation of the measured metabolite concentrations. 
This assumption, however, holds true only to a certain point.
We demonstrated in this study that it is possible to resolve and individually quantify the IMCL13 and EMCL15 
signals by accounting for their chemical shift difference and its dependence on the cardiac fibre angle. However, 
based on the LCModel results it was not possible to establish the same relationship for the less-pronounced IMCL 
and EMCL moieties. This failure can be partly explained by the low signal amplitudes of the respective reso-
nances, which make reliable peak fitting difficult, especially in the presence of other signals overlapping the reso-
nance in question. Furthermore, it has been shown in previous studies13–16 that the MR spectrum of triglycerides, 
in the absence of any susceptibility effects due to muscular structure, exhibits a resonance peak from CH2 groups 
next to the glycerol resonance at 2.3 ppm. Therefore, the signal fitted with a single basis function at 2.3 ppm 
reflects the sum of the IMCL signal at that frequency and EMCL signal, which corresponds to the IMCL21 signal 
but is shifted due to susceptibility effects. Hence, the chemical shift difference between the EMCL23 signal and the 
IMCL21 signal cannot be determined from the LCModel fit. Moreover, the basis functions used to fit IMCL21 
and the combined I/E23 signal contain a second very broad resonance upfield to the main peak of these basis 
functions (Fig. 4). The two components of these basis functions were introduced in a previous study to approxi-
mate lipid contributions that were not well-specified and could not be further resolved in the spectra acquired in 
that study, presumably due to the low static field applied. However, the data of this study show that these broad 
features do not capture the different spectral components of the lipids in the spectra very well, and instead result 
in overfitting of the data and a visible dip in the residual. Two additional resonances in the triglyceride spectrum 
are not considered by the LCModel fit: one at 1.6 ppm and another at 2.75 ppm, originating from the methyl 
protons next-nearest to the glycerol and from polyunsaturated fatty acids, respectively. These resonances were 
likely difficult to resolve in vivo, due to low signal amplitudes, and were therefore neglected in the underlying 
model. Nevertheless, by summing the residuals of the acquired spectra from this study (again excluding the spec-
tra where EMCL15 was not correctly fit), a low-amplitude resonance peak became apparent at about 2.7 ppm (see 
Fig. S4.3). It is clear from these considerations that 1H CMRS quantification could be greatly improved by incor-
porating the extensive prior knowledge regarding the complex spectral structure of the triglyceride spectrum into 
the models used for peak fitting procedures, namely: (1) the known structure of the triglyceride spectrum with all 
relevant resonances13,14; (2) the correlations of different peak amplitudes to one another within the triglyceride 
volunteer
IMCL13 EMCL15 IMCL09 EMCL11
Cr ratio CRLB [%] Cr ratio CRLB [%] Cr ratio CRLB [%] Cr ratio CRLB [%]
1 1.47 5 1.32 5 — — 0.23 19
2 1.82 4 1.60 4 0.16 20 0.15 23
3 3.43 2 0.73 9 0.48 8 0.27 13
4 2.92 2 1.06 5 0.57 4 0.08 19
5 3.94 1 1.33 4 0.49 6 0.66 6
6 1.83 3 0.63 8 0.24 10 0.21 13
7 3.30 2 0.32 21 0.69 9 0.35 14
8 0.97 4 0.19 14 0.25 9 0.12 24
9 1.80 2 0.42 6 0.30 7 0.15 12
10 1.81 4 0.40 17 0.55 9 0.08 42
Mean  
(SD)
2.33  
(0.94)
2.90  
(1.22)
0.80  
(0.47)
9.3  
(5.69)
0.24  
(0.17)
9.11  
(4.23)
0.23  
(0.17)
18.50  
(9.39)
Table 2. Metabolite/Cr ratios and Cramér-Rao-Lower-Bounds (CRLB) from LCModel with chemical shift of 
lipid components entered as prior knowledge. Cr ratios and CRLBs of the four most prominent lipid moieties 
are given after re-fitting the spectra with LCModel, this time using prior knowledge regarding the angular 
dependence of the chemical shift of EMCL. To this end, the undocumented ‘chsimu’ parameter was employed, 
which allowed fixing of the chemical shifts of these lipid components to frequency values calculated from 
equations (3), (4), and (5). Means and standard deviations (SD) over all volunteers are given in the bottom 
row. Compared to the fit without prior knowledge, the CRLBs of IMCL components appear to increase only 
marginally, while CRLBs of EMCL components decrease substantially in most cases.
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spectrum to better estimate concentrations of overlapping peaks as demonstrated by Hamilton et al.16; (3) the 
knowledge that the chemical shift difference between EMCL and IMCL signals is a result of susceptibility effects, 
and is therefore equal between all IMCL resonances and the corresponding EMCL resonances9; and (4) the 
dependence of the chemical shift difference on the angle θ between cardiac fibres and the main magnetic field B0, 
as described by equation (2), as well as the voxel angle α, after a proper relationship between α and θ has been 
established. An early indication of the expected improvement in such measures was given in this study: fitting the 
data a second time, and fixing the chemical shifts of the four most prominent lipid moieties according to the val-
ues calculated by equations (3) to (5), led to a substantial decrease in the CRLBs of the EMCL signals and a statis-
tically significant correlation between the EMCL15/Cr ratio and the volunteers’ BMIs was found. Hence, 
developing and verifying a quantification model capable of capturing the complexity of triglycerides in muscle 
and cardiac muscle spectra will be a challenging but worthy future endeavour.
The improved spectral quality achievable with the IVS-McPRESS method shown here, together with more 
sophisticated quantification routines as outlined above, may allow deeper insight into cardiac metabolism in 
healthy subjects and diverse patient groups. In particular, our data show a strongly significant correlation between 
the IMCL21/Cr ratio ( = .p 0 01, r 0 84= . ), and the EMCL15/Cr ratio (p 0 04= . , r 0 65= . ) and the volunteers’ 
BMIs, suggesting that a higher BMI is linked to a greater concentration of intramyocellular unsaturated fatty acids 
as well as extramyocellular saturated fatty acids. Furthermore, the number of extracellular triglyceride molecules, 
as well as the number of saturated bonds in intramyocellular fatty acids, appears to increase with increasing BMI; 
the signals from EMCL11/Cr ratios, and IMCL13/Cr ratios, namely the number of end groups in EMCL and the 
number of methylene groups in IMCL, respectively, exhibit strong correlations with BMI ( = .r 0 56, and r 0 61= .  
respectively), although these are not statistically significant. Another strong but non-statistically-significant cor-
relation was found between BMI and taurine/Cr ratios ( = .r 0 62). While a linear correlation seems plausible 
between increasing BMI and lipid levels from both compartments, further studies on larger samples are required 
to confirm these changes and establish their statistical significance and clinical relevance. Moreover, further anal-
ysis on a broader database may reveal more complex relationships between other lipid moieties and metabolite 
concentrations and BMI that cannot be seen in this study, due to the small sample size.
Conclusions
For the first time, the feasibility of IVS-McPRESS, a metabolite-cycled non-water-suppressed 1H CMRS tech-
nique, to improve spectral quality in 1H MRS in the human myocardium was demonstrated, and the data suggest 
that separation and individual analysis of IMCL and EMCL signals in the myocardium is possible. Prior knowl-
edge of the angular dependence of the chemical shift of EMCL signals was used to confirm quantification results 
and their assignment to the different lipid compartments, and strong correlations between concentrations of 
different lipid moieties and volunteers’ BMIs were found. These results indicate that it is possible to reliably 
resolve signals from different lipid compartments at 3 T, provided the myofibre orientation within the voxel of 
interest with the main magnetic field is between θ− . ° < < . °24 5 24 5 . This will enable improved 1H MRS quanti-
fication accuracy in studies of myocardial metabolism, and will also prove useful in skeletal muscle applications.
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